New York Presbyterian Queens is a clinical research site located in Flushing, New York, United States 11355.
Crixeo Clinical Trials Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Presbyterian Queens has participated in 10 clinical trials with 3 currently active.
Therapeutic areas: Primary Prevention of Atherosclerotic Cardiovascular Disease, Proteinuric Kidney Disease, Squamous Cell Carcinoma (SCC).
Sponsors: Novartis Pharmaceuticals, Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals.
Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York Presbyterian Queens has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Presbyterian Queens has 10 clinical trials on record, with 3 currently active. Their work covers Primary Prevention of Atherosclerotic Cardiovascular Disease, Proteinuric Kidney Disease, Squamous Cell Carcinoma (SCC).
New York Presbyterian Queens has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.